RANBP2 and inflammatory myofibroblastic tumor: Although RANBP2-ALK–rearranged eIMS has previously been identified as an aggressive AP-IMT subtype,19,22 we also observed life-threatening complications associated with a CLTC-ALK–rearranged IMT.